Efficacy of seasonal allergic rhinitis using an 810 nm diode laser system: 810 nm diode laser for allergic rhinitis

• Published in: LASER THERAPY 2019, Vol.28(1), pp.11-18
• Main Authors: Sasaki, Katsumi, Ohshiro, Takafumi, Sakio, Reiko, Toriumi, Masahiro, Hatano, Asako, Fukazawa, Emi, Kono, Takeyuki, Yoshihama, Keisuke, Ogawa, Kaoru, Ohshiro, Toshio
• Format: Article
• Language: eng ; jpn
• Subjects: anti-histamine; Cedar pollinosis; diode laser; immunoglobulin E; RAST test; Seasonal Allergic Rhinitis; type 1 allergic reaction
• ISSN: 0898-5901; 1884-7269
• DOI: 10.5978/islsm.28_19-OR-01

Background and Aims: Allergic rhinitis annually reach epidemic proportions in Japan. Approximately30 to 40% of the population suffers from allergic rhinitis during the spring season. Symptoms compriserhinorrhea, nasal congestion, and sneezing accompanied by irritation and itching of the eyes. The OhshiroClinic started using the conventional Nd:YAG laser for the treatment of allergic rhinitis in 1993, andfrom 2005 we started using a diode laser-pumped Nd:YAG laser. From 2010, we adopted a novel 810 nmdiode laser, and the present retrospective study examined the efficacy rate of the treatment of allergicrhinitis in the 2018 season with this system, compared with a previous study in 2011. We aimed to confirmthe degree of improvement for each symptom to evaluate effectiveness of the diode laser treatment. Subjects and methods: Between January 8, 2018 and April 30, 2018, a large number of patients consulted our clinic with the major complaint of seasonal allergic rhinitis. They underwent a blood test, and theantigen-specific serum IgE antibody titers were measured for a definitive diagnosis of cedar pollinosis. Atotal of 211 target patients were treated during the trial period. The average age of the target group was36.3 years, 134 males, and 77 females. The target patients were treated with lower nasal turbinate mucosalirradiation using a diode laser (ADL-20, Asuka Medical) delivering 810 nm at 7.5 W, with a total energyper treatment of 240 J/cm2. We adopted a five-step evaluation in accordance with the Japanese Guidelines for Allergic Rhinitis 2014 for the symptoms of rhinorrhea, sneezing and nasal obstruction. We assessed the degree of improvement in the severity of these symptoms following diode laser treatment from baselineto one month after treatment, in addition to assessing patient satisfaction with the degree of improvementin their quality of life (QOL). Results: The 211 patients positive for cedar pollinosis by the antigen-specific serum IgE antibody tests were broken down by month by number and by improvement, no change or exacerbation as follows. January, 18 patients: 33.4%, 44.4% and 22.2%, respectively. February, 29: 10.4%, 44.4% and 22.2%, respectively. March, 146: 60.3%, 31.5% and 8.2%, respectively. April, 18: 77.8%, 16.7% and 5.5%, respectively. The monthly respective improvement, no change or worse patient QOL as percentages were as follows: January:16.7%, 44.4% and 38.9%. February: 17.3%, 13.8% and 68.9%. March: 61.6%, 29.5% and 8.9%. April: